The medical technology company BoneSupport listed on the Stockholm Stock Exchange, NASDAQ, Stockholm Small Cap, two days before midsummer at a valuation of about 1.4 billion.
Almi Invest is a partner in BoneSupport through Teknoseed which conducted its first investment already in 2007.
BoneSupport develops injectable bone filling material bioceramic Cerament absorbed by the body while stimulating the growth of new bone. Cerament used for example in trauma, fractures caused by osteoporosis, bone infection and to fix screws and implants in bone.
– It is very gratifying to note that BoneSupport completed such a successful listing, says Marcus Skärbäck, investment manager at Almi Invest. With good access to capital and a strong management team and board of directors, the company has good prospects for further expansion.
In connection with the listing took BoneSupport the SEK 500 million from new and existing investors. The money will be used for continued market expansion in Europe and the US and to further clinical studies, including with the aim of getting the product Cerament G approved in the United States.
